We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis.
- Authors
de Lavallade, Hugues; Apperley, Jane F; Khorashad, Jamshid S; Milojkovic, Dragana; Reid, Alistair G; Bua, Marco; Szydlo, Richard; Olavarria, Eduardo; Kaeda, Jaspal; Goldman, John M; Marin, David
- Abstract
Imatinib is remarkably effective in treating newly diagnosed patients with chronic myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come from a single multicenter study in which some of the patients were censored for diverse reasons. Here, we report our experience in treating patients at a single institution in a setting where all events were recorded.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Vol 26, Issue 20, p3358
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.15.8154